"I have been seeing Boyd for almost 2 years for severe chronic migraines. I have seen great results in the reduction of my headaches since I've started acupuncture with him when no other treatment or medication would work. Boyd is very knowledgeable about acupuncture and stays up to date with current practices and techniques. I ask him a lot of questions during our sessions, and he's always able to provide a thorough response that I can easily understand. He listens thoroughly to issues and problems and works with me to come up with the best treatment at each appointment. He's a pleasure to talk to during each session and always ensures I am completely at ease during every step. The only problem I have is that I waited so long to begin acupuncture treatment with him!"
Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial
Abstract
Background:
Our aim was to assess the efficacy of a part-standardised verum acupuncture procedure, in accordance with the rules of traditional Chinese medicine, compared with that of part-standardised sham acupuncture and standard migraine prophylaxis with beta blockers, calcium-channel blockers, or antiepileptic drugs in the reduction of migraine days 26 weeks after the start of treatment.
Methods:
This study was a prospective, randomised, multicentre, double-blind, parallel-group, controlled, clinical trial, undertaken between April 2002 and July 2005. Patients who had two to six migraine attacks per month were randomly assigned verum acupuncture (n=313), sham acupuncture (n=339), or standard therapy (n=308). Patients received ten sessions of acupuncture treatment in 6 weeks or continuous prophylaxis with drugs. Primary outcome was the difference in migraine days between 4 weeks before randomisation and weeks 23-26 after randomisation. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN52683557.
Results:
Of 1295 patients screened, 960 were randomly assigned to a treatment group. Immediately after randomisation, 125 patients (106 from the standard group) withdrew their consent to study participation. 794 patients were analysed in the intention-to-treat popoulation and 443 in the per-protocol population. The primary outcome showed a mean reduction of 2 .3 days (95% CI 1.9-2.7) in the verum acupuncture group, 1.5 days (1.1-2.0) in the sham acupuncture group, and 2.1 days (1.5-2.7) in the standard therapy group. These differences were statistically significant compared with baseline (p<0.0001), but not across the treatment groups (p=0.09). The proportion of responders, defined as patients with a reduction of migraine days by at least 50%, 26 weeks after randomisation, was 47% in the verum group, 39% in the sham acupuncture group, and 40% in the standard group (p=0.133).
Interpretation:
Treatment outcomes for migraine do not differ between patients treated with sham acupuncture, verum acupuncture, or standard therapy.
Plain Language Commentary:
Acupuncture is more effective in preventing migraines than standard pharmaceutical drugs commonly prescribed, such as Topamax® or Inderal®. So-called "Sham" acupuncture is widely perceived by many scientists to be an ineffective placebo because it is not inactive - at best it is sub-optimal acupuncture.
SOURCE: Lancet Neurol. 2006 Apr;5(4):310-6; Diener HC, Kronfeld K, Boewing G, Lungenhausen M, et al; Department of Neurology, University Essen, Essen, Germany